Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
The objective of the study was to evaluate the effects of raloxifene and estrogen progesterone (E + P) combination on symptoms, endometrium, and lipid profile in postmenopausal women. Ninety healthy postmenopausal women were enrolled and allocated to three groups namely E + P, raloxifene, and contro...
Main Authors: | Anuradha Dogiparthi, Neelam Aggarwal, Vanita Suri, Radhika Srinivasan, Sarla Malhotra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | Journal of Mid-Life Health |
Subjects: | |
Online Access: | http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2010;volume=1;issue=1;spage=14;epage=18;aulast=Dogiparthi |
Similar Items
-
Effects of Raloxifene Combined with Low-dose Conjugated Estrogen on the Endometrium in Menopausal Women at High Risk for Breast Cancer
by: Andrea Lucia Bastos Carneiro, et al.
Published: (2021-01-01) -
Induction of mitochondrial apoptotic pathway by raloxifene and estrogen in human endometrial stromal ThESC cell line
by: Ivana Nikolic, et al.
Published: (2016-05-01) -
New treatment paradigm of combined raloxifene and conjugated estrogen for postmenopausal symptoms in VCD-ind
by: Marwa N. Emam, et al.
Published: (2017-08-01) -
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)